5JE Stock Overview
A medTech company, provides infection prevention technology and solutions in orthopedics, cardiology, neurology, urology, and vascular access areas in the United States, Sweden, Malaysia, India, Bangladesh, Indonesia, the Kingdom of Saudi Arabia, and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 4/6 |
| Past Performance | 0/6 |
| Financial Health | 5/6 |
| Dividends | 0/6 |
Community vs My Fair Value
Create NarrativeSelect a narrative for quick price alerts from the community, or create your own.
Bactiguard Holding AB (publ) Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | SEK 3.09 |
| 52 Week High | SEK 6.62 |
| 52 Week Low | SEK 1.97 |
| Beta | 0.53 |
| 1 Month Change | 22.13% |
| 3 Month Change | 22.62% |
| 1 Year Change | -46.91% |
| 3 Year Change | -65.47% |
| 5 Year Change | n/a |
| Change since IPO | -82.98% |
Recent News & Updates
Recent updates
Shareholder Returns
| 5JE | DE Medical Equipment | DE Market | |
|---|---|---|---|
| 7D | -5.5% | -5.6% | -0.9% |
| 1Y | -46.9% | -14.7% | 14.1% |
Return vs Industry: 5JE underperformed the German Medical Equipment industry which returned -11.8% over the past year.
Return vs Market: 5JE underperformed the German Market which returned 15.8% over the past year.
Price Volatility
| 5JE volatility | |
|---|---|
| 5JE Average Weekly Movement | 15.5% |
| Medical Equipment Industry Average Movement | 6.6% |
| Market Average Movement | 6.5% |
| 10% most volatile stocks in DE Market | 12.7% |
| 10% least volatile stocks in DE Market | 3.1% |
Stable Share Price: 5JE's share price has been volatile over the past 3 months compared to the German market.
Volatility Over Time: 5JE's weekly volatility has increased from 10% to 16% over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2005 | 147 | Christine Lind | www.bactiguard.com |
Bactiguard Holding AB (publ), a medTech company, provides infection prevention technology and solutions in orthopedics, cardiology, neurology, urology, and vascular access areas in the United States, Sweden, Malaysia, India, Bangladesh, Indonesia, the Kingdom of Saudi Arabia, and internationally. It also operates through license partnerships with global MedTech companies that apply the technology to medical devices and sell them under own brand and co-branded. The company also has a portfolio of wound management products, such as Hydrocyn Aqua, an antimicrobial solution and gel for improved wound healing; and surgical sutures comprising non-absorbable, natural absorbable, synthetic absorable, and specialty sutures.
Bactiguard Holding AB (publ) Fundamentals Summary
| 5JE fundamental statistics | |
|---|---|
| Market cap | €113.39m |
| Earnings (TTM) | -€2.28m |
| Revenue (TTM) | €22.89m |
Is 5JE overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 5JE income statement (TTM) | |
|---|---|
| Revenue | SEK 247.63m |
| Cost of Revenue | SEK 35.49m |
| Gross Profit | SEK 212.14m |
| Other Expenses | SEK 236.78m |
| Earnings | -SEK 24.64m |
Last Reported Earnings
Mar 31, 2025
Next Earnings Date
Jul 15, 2025
| Earnings per share (EPS) | -0.70 |
| Gross Margin | 85.67% |
| Net Profit Margin | -9.95% |
| Debt/Equity Ratio | 37.4% |
How did 5JE perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/05/23 20:06 |
| End of Day Share Price | 2025/05/23 00:00 |
| Earnings | 2025/03/31 |
| Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Bactiguard Holding AB (publ) is covered by 1 analysts. 2 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Kristofer Liljeberg-Svensson | Carnegie Commissioned Research |